Estudio de MK-1484 como monoterapia y en combinación con pembrolizumab en tumores sólidos avanzados o metastásicos
The purpose of this study is to assess the safety and tolerability and to establish a preliminary recommended Phase 2 dose (RP2D) of MK-1484 administered as monotherapy and in combination with